US OptionsDetailed Quotes

BTAI240816C4000

Watchlist

0.30
0.000.00%

15min DelayClose Jul 22 09:42 ET

0.00High0.00Low

BioXcel Therapeutics Stock Discussion

WJJG

Jul 16 06:14

Good news! 90% increase Q over Q

$BioXcel Therapeutics(BTAI.US)$ …The Company expects unaudited revenue of approximately $1.1 million for the three months ended June 30, 2024, representing an increase of approximately 90% quarter over quarter and approximately 141% compared to the same period in 2023. Revenue growth was driven by an increase in contracting with psychiatric care clinics and behavioral health facilities using a small commercial team…

Trytosaveabit

Jun 26 10:59

Sometimes! Nice!

$BioXcel Therapeutics(BTAI.US)$ Sometimes when the chart hold decent? It pays to hold a Day trade overnight! But only when the chart says so and even then it can be a risk if bad news comes overnight!

Trytosaveabit

Jun 25 07:34

Again MooMoo not showing true PA?

$BioXcel Therapeutics(BTAI.US)$ Note at 8:03 MooMoo has a high of 1.34! But as you see in pictures of chart and tic x tic the high was 1.47?

Trytosaveabit

Jun 25 06:03

News

$BioXcel Therapeutics(BTAI.US)$ Reuters · just BioXcel Therapeutics Announces Positive Topline Results From Post-Marketing Requirement Study Evaluating Prn Treatment of Igalmi™ (Dexmedetomidine) Sublingual Film for Agitation Associated With Bipolar Disorders or Schizophrenia

huEYc

Jun 5 12:01

$BioXcel Therapeutics(BTAI.US)$ why price moving down without break?

Meltyy

May 22 02:52

Biotech Stock Catalyst Watchlist 👀

🎯 Ph 2 readouts in Q2 2024...
$Iovance Biotherapeutics(IOVA.US)$ Phase 2
$Supernus Pharmaceuticals(SUPN.US)$ Phase 2a
$BRANDES INTERNATIONAL ETF(BINV.US)$ Phase 2a
$MorphoSys(MOR.US)$ Phase 2
$Nuvation Bio(NUVB.US)$ Phase 2
$ALX Oncology(ALXO.US)$ Phase 2
$BioXcel Therapeutics(BTAI.US)$ Phase 2
$Purple Biotech(PPBT.US)$ Phase 2
$Arcus Biosciences(RCUS.US)$ Phase 2
$Medicenna Therapeutics(MDNAF.US)$ Phase 2b
$Affimed NV(AFMD.US)$ Phase 2
$Barinthus Biotherapeutics(BRNS.US)$ Phase 2b...

Jaguar8

May 21 06:10

$BioXcel Therapeutics(BTAI.US)$
NEWS
BioXcel Therapeutics Announces Oral and Poster Presentations at the 2024 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting
BioXcel Therapeutics (Nasdaq: BTAI) has announced that Dr. Rob Risinger will present both oral and poster presentations at the 2024 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting from May 28 to 31 in Miami Beach, FL. The presentations will focus on the comparison of sublingual Dexmedetomidine wit...

JESSE JAMES8832

May 9 06:24

news

$BioXcel Therapeutics(BTAI.US)$BioXcel Therapeutics Q1 2024 GAAP EPS $(0.87) Beats $(1.04) Estimate, Sales $582.000K Beat $464.000K Estimate

Jaguar8

Apr 24 09:31

$BioXcel Therapeutics(BTAI.US)$
NEWS
BioXcel Therapeutics Announces Late-Breaking Abstract on Preliminary Findings from Phase 2 Investigator-Sponsored Trial of BXCL701 and KEYTRUDA® in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) Selected for Presentation at 2024 ASCO Annual Meeting
The late-breaking abstract on preliminary findings from the Phase 2 trial of BXCL701 and KEYTRUDA® in metastatic pancreatic ductal adenocarcinoma has been selected for presentation at the 2024 ASCO Annual Meeti...

Trytosaveabit

Apr 10 06:08

Hmm?

$BioXcel Therapeutics(BTAI.US)$ BioXcel Therapeutics Announced Details Regarding The Planned Design Of Its Upcoming TRANQUILITY In-care Phase 3 Trial Of BXCL501 For Agitation Associated With Alzheimer's Dementia

No comment yet